What should you know about HCTZ and kidney stones?

HCTZ may be prescribed in selected people with recurrent calcium kidney stones, but it is not suitable for everyone. It is a thiazide diuretic that changes kidney handling of sodium and can reduce calcium loss in urine. The choice depends on stone type, kidney function, blood pressure, hydration, and other medicines.

Kidney stones form when substances in urine become concentrated and crystallise. Dehydration can make this easier. HCTZ can also alter salts in the blood and may cause increased urination, dizziness, or thirst. It does not dissolve every stone and does not replace assessment of a new episode of flank or abdominal pain. A clinician may need urine and blood tests to understand your risk.

Take HCTZ only as prescribed and keep follow-up appointments for blood pressure, kidney function, and electrolyte checks. Ask how much fluid is appropriate for you; fluid advice may need adjustment if you have heart or kidney disease. Do not stop the medicine or add supplements without advice. A GP consultation can help decide whether imaging, such as an abdominal ultrasound, is appropriate.

Seek urgent care for severe or persistent flank pain, fever with urinary symptoms, repeated vomiting, inability to pass urine, or blood in the urine with worsening pain. These signs can indicate obstruction or infection. Call emergency services for collapse, severe weakness, confusion, or breathing difficulty.

Ask whether your stones are likely to contain calcium, whether HCTZ fits your blood-pressure plan, which electrolytes need monitoring, and how to respond to vomiting or dehydration. Discuss your other medicines, gout history, pregnancy or breastfeeding, and the symptoms that should prompt imaging.